University of Thessaly (UTH)
Διερεύνηση της έκφρασης γονιδίων τα οποία ενέχονται στο μεταβολισμό των λιπιδίων στην οστεοαρθρίτιδα και μηχανισμοί ρύθμισης αυτών: in vitro και in vivo μελέτη
Abstract
dc:descriptionPurpose: The purpose of the present thesis is the investigation of the molecular basis of lipid metabolism in osteoarthritic chondrocytes through evaluation of the expression of genes that control cholesterol homeostasis, such as Sterol Regulatory Element Protein 2 (SREBP–2) and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the implicated mechanisms controlling their activation, and the regulation of cholesterol efflux related genes using microRNAs. In addition, we developed an experimental animal model of OA in order to highlight potential therapeutic molecules for inhibiting disease progression in vivo.Methods: Expression of genes involved in lipid metabolism was evaluated using real-time PCR and Western blot. We treated chondrocytes with TGF-β1 and integrin inhibitor and investigated the signal transduction pathway responsible for the activation of lipid metabolism genes. We also treated chondrocytes with miR-33a and anti-miR-33a and investigated their role on cholesterol synthesis and on the expression of cholesterol efflux related genes. Finally, we developed animal model of OA induced by anterior cruciate ligament transection in rabbits.Results: We observed that SREBP–2, HMGCR, integrin aV, TGF–β1, phosphor-PI3k and phosphor-Akt expression levels were significantly upregulated in osteoarthritic chondrocytes compared to normal. Treatment of normal chondrocytes with TGF–β1 resulted in SREBP–2, HMGCR, phospho–PI3K and MMP–13 upregulation. The use of the pharmacological inhibitor of TGF–β receptor resulted in downregulation of SREBP–2 expression while integrin blockage resulted in dramatic reduction of SREBP–2, HMGCR, phospho–PI3K and MMP–13 expression levels accompanied by elevated levels of ACAN. We also found that miR–33a expression levels were significantly elevated in osteoarthritic chondrocytes compared to normal, in accordance to SREBP–2’s upregulation and that miR–33a expression was increased in a time–dependent manner after TGF–β1 activation. Treatment of normal chondrocytes with miR–33a resulted in significant reduction of ABCA1 and ApoA1 mRNA expression levels, accompanied by increased levels of MMP–13. Introduction of antisense oligonucleotides directed against miR–33a, resulted in strongly increased ABCA1 and ApoA1 expression levels, while it also caused reduced expression of MMP–13. Our in vivo results showed that SREBP–2 expression levels were significantly elevated in rabbit OA chondrocytes compared to normal. Intra-articular administration of TGF–β receptor inhibitor resulted in a statistically significant reduction in the expression levels of SREBP–2, COLX and MMP–13, whereas COL2A1 and ACAN were significantly increased.Conclusion: Our novel findings suggest that SREBP–2 is crucially involved in OA pathogenesis and provided evidence for its TGF–β1–induced activation through ITGAV/PI3K/Akt pathway, pointing towards the use of integrin inhibitors as possible molecular targets for osteoarthritis treatment. Moreover, we provide novel evidence for the implication of miR–33a, a SREBP–2 intronic microRNA, in OA pathogenesis, identifying it as a dual regulator of cholesterol synthesis and cholesterol efflux–related genes in OA chondrocytes, suggesting its potential use as a novel target for the amelioration of OA phenotype. We finally found that TGF–β inhibition in vivo may be a new potential therapeutic approach for the treatment of the disease.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kostopoulou, Fotini
- Κωστοπούλου, Φωτεινή
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34943